stella
beta
A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics — Stella
Recruiting
Back to Prostatic Neoplasms trials
Trial locations
(1 site)
United States
Precision Point Specialty LLC PPS Analytics, a Specialty Networks LLC Company, Cleveland, Ohio
View full record on ClinicalTrials.gov